Oxford Nanopore Technologies is one of the most successful companies backed by fully listed IP Group. The focus on nanopore-based life science research tools for DNA / RNA means that there is a fast-growing market to exploit.
The company has developed the world’s only pocket-sized portable sequencer called MinION. This means that it can be used outside the laboratory. There is also software sold on an annual licence.
The 2023 life science tools revenues of £165m to £175m are being targeted with a target gross margin of more than 60%. Losses should reduce by 2023.
Prior to the start of u...
